Clinical Trial Update: Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating safety and efficacy of combining whole-brain low-dose radiotherapy with a PD-1 inhibitor and intrathecal chemotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Intrathecal chemotherapy
• PD-1 inhibitor
• Whole Brain Low-Dose Radiotherapy (LDRT) (low-dose radiotherapy)

Snippet

Sponsor: Sichuan University | Conditions: NSCLC, Low Dose Radiotherapy | Phase 1 | Status: RECRUITING